Atlas Trials

Dosing Study of Replagal in Patients With Fabry Disease

Clinical trial NCT00068107 · COMPLETED

Trial details

NCT number
NCT00068107
Sponsor
Baylor Research Institute
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Fabry Disease
Start date
2003-09-01
Primary completion
2013-12-01
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.